Authors


Ruth Ann Vleugels, MD, MPD, MBA

Latest:

Final Thoughts on JAK Inhibitor for AD

Experts conclude their discussion highlighting key takeaways and considerations when using Janus Kinase (JAK) inhibitors as treatment for atopic dermatitis (AD).


Henry W. Lim, MD

Latest:

Poster Detailing Safety of JAK Inhibitors Wins Award at AAD Annual Meeting

Henry Lim, MD, shares insights on JAK inhibitor safety and the poster presented at the AAD Annual Meeting


Aaron Funk

Latest:

Administrative Burden of Prescribing Biologics

Prescribing biologics can require a complex approval and claims process. Creating a tiered system based on office workload can help practices understand and allocate staff time. Outsourcing approvals to pharmacies where possible can also streamline the process.


Andrew Blauvelt, MD, MBA

Latest:

Patient Case #3: 32-Year-Old Male With AD

Expert dermatologists review a final case about a 32-year-old male with AD, highlighting systemic therapy as first-line treatment.


Jack Arbiser, MD, PhD

Latest:

The Connection Between COVID Lung Lesions and Skin Lesions

Jack Arbiser, MD, PhD conducted research in a recent study to observe the impact R-propranolol has on broad-spectrum anti-coronavirus activity.


Michael Whitworth, DO, FAOCD, FAAD

Latest:

Harnessing the Potential of Placental Allografts

Placental tissues provide a promising alternative for addressing cutaneous reconstruction while maintaining the most cosmetically pleasing outcome.


Jacqueline Tran, BS

Latest:

Epidermolysis Bullosa: The Worst Disease You’ve Never Heard Of

Epidermolysis bullosa is a broad term used to identify a group of genetic disorders that result in skin blistering and fragility.


Jane Mast, PhD, DMSc, MPAS

Latest:

Jane Mast, PhD, DMSc, MPAS: Having a Passion for Patients

Mast spoke with Dermatology Times about her conference workshop, what she's looking forward to ahead of this week's SDPA conference, and the importance of always maintaining a passion for patients.


Michael Levy, MD, PhD

Latest:

Endoscopic Thoracic Sympathectomy Surgery for Hyperhidrosis: Patient and Physician Perspectives

Patient Cole Villaflor, his mother, and Michael Levy, MD, PhD, provide insights into Cole’s hyperhidrosis diagnosis and subsequent endoscopic thoracic sympathectomy surgery.


Jessica Nunn, CPA

Latest:

5 Simple Financial Tips for Dermatologists and Their Practices

Your practice’s finances are the key to long-term business success and understanding them doesn’t have to feel like a puzzle.


Nicholas Golda, MD, FACMS

Latest:

Nicholas Golda, MD Shares Pearls to Manage Bleeding in Mohs Surgery

Golda explains why he prefers using tranexamic acid to control bleeding in granulated wounds.


Alice Gottlieb, MD, PhD

Latest:

2024 Masterclasses in Dermatology Sneak Peek With Alice Gottlieb, MD, PhD

Learn what makes the Masterclasses in Dermatology conference a unique educational opportunity, and take a quick poll to tell us what you want to learn.


Meghan McManama, DNP, DipACLM

Latest:

Whole-Person Health is the Key to Reducing Disparities and Driving Patient Trust

As we continue to face the COVID-19 pandemic and its long-term consequences, it is more important than ever for providers to build trust with patients.


Julia Bonavitacola

Latest:

Research Presented at AAD Explores Relationship Between Vitiligo and Skin Tone Bias in Google Searches

Several posters presented at the American Academy of Dermatology Annual Meeting explored the topic of skin tone bias related to vitiligo in Google and internet search platforms.


Paul Friedman, MD

Latest:

Paul Friedman, MD: An In-Depth Review of UltraClear Laser-Coring

Paul Friedman, MD, discusses the benefits of UltraClear Laser-Coring, patient downtime, how to decide what devices to have in your clinic, and more.


Ashley Nicole Elsensohn, MD, MPH, FAAD

Latest:

HS Excision Clinical Pearls Discussed at AAD Annual Meeting

How can you improve excision care for your patients with hidradenitis suppurativa? Ashley Nicole Elsensohn, MD, MPH, FAAD, shared clinical pearls at the AAD Annual Meeting.



Ken Nuss

Latest:

New IRS Rule Lets Early Retirees Take More Money from Plans

Fixed-annuity guarantees more income for penalty-free early withdrawals from retirement plans.


Nitin Joshi, PhD

Latest:

An Inside Look in the Development of CGB-500 For Atopic Dermatitis Treatment

Nitin Joshi, PhD, shared CAGE Bio’s development of CGB-500 and why phase 2 EASI scores have the company’s scientific advisory board optimistic.


Lisa Grabl

Latest:

Marketing Tips for Your Medical Practice

Harnessing digital marketing tools can help your medical practice grow.



Sydney Givens, PA-C

Latest:

Patients Want Cosmeceutical Recommendations, What Do You Need to Know?

Sydney Givens, PA-C, reviews how she discusses cosmeceuticals with her patients and what resources she offers.


Ashley Gallagher

Latest:

FDA Organizations Issue Joint Paper on Responsible and Ethical Use of Artificial Intelligence in Medical Research

The paper was authored and issued by the FDA Center for Biologics Evaluation and Research, Center for Drug Evaluation and Research, Center for Devices and Radiological Health, and Office of Combination Products.



Ariana Pelosci

Latest:

FDA Grants Fast Track Designation to Nemvaleukin Alfa for Mucosal Melanoma

Immunotherapy agent nemvaleukin alfa was granted an FDA fast track designation for the treatment of patient’s mucosal melanoma for previously undergone treatment with an anti-PD-L1 therapy.


Dina El-Sherif, MBA

Latest:

How Can Patients Benefit From New Device, TruFacial?

Founder Dina El-Sherif, MBA, gave an in-depth overview of the at-home facial rejuvenation device and its 3-step process at AAD 2024.



Michael Gold, MD

Latest:

Gearing Up For SCALE 2023 With Co-Director, Michael Gold, MD

Gold encourages all attendees to feel welcome as they attend both cosmetic and medical dermatology sessions.


Mia Dekel

Latest:

An Overview of Pediatric Psoriasis

In one-third of cases of psoriasis, disease onset occurs in the first or second decade of life, although it may not be diagnosed until the patient has reached adulthood.


Diego Ruiz Dasilva, MD, FAAD

Latest:

Unmet Needs in the Treatment of Atopic Dermatitis

Diego Ruiz Dasilva, MD, FAAD, reviews the unmet needs and barriers in the treatment landscape of atopic dermatitis.

© 2024 MJH Life Sciences

All rights reserved.